News
Joseph Saseen, PharmD, discussed the importance of knowing lipoprotein a (Lp[a]) levels to enable clinicians to provide the ...
The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...
Patients with chronic lymphocytic leukemia (CLL) who experience Richter transformation have a poor prognosis, but ibrutinib ...
Vegetables, fish oil, fruit, and high-fiber foods have anti-inflammatory effects, while low-fiber bread and animal fats are ...
An expert on the intersection of HIV and menopause, Bridgette J. Picou, LVN, ACLPN, The Well Project, explains the importance ...
A report published today by the American Foundation for Suicide Prevention underscores the potential of the collaborative ...
Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.
The findings indicate that the currently approved 600-mg dose of intravenous ocrelizumab is optimal to significantly slow ...
Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.
A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth, shares how health care leaders are advancing value-based care through improved data strategies, ...
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy, highlights key policy updates that are impacting managed care pharmacy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results